Homology Medicines
Rare Disease research & cures
Based in MA
🤖
AI Overview
With $150K in lobbying spend across 9 quarterly filings, Homology Medicines is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2020 to 2022.
$150K
Total Spend
3
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $30K |
| 2021 | $80K |
| 2022 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED
- •Rare Disease Research and cures through gene editing and gene therapy.
- •Drug pricing, gene therapy, and rare disease funding generally;
- •Advancing Access to Precision Medicine;
- •Newborn Screening Saves Lives Reauthorization Act;
- •Genome Editing Threat Assessment Act;
- •Medical
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.